November 15, 2019 / 2:39 AM / a month ago

Judge upholds Endo patents on Adrenalin in loss for Pfizer generic unit

A judge on Thursday dealt a major setback to Pfizer Inc’s Hospira in its bid to launch a generic version of Endo International plc’s emergency allergy treatment Adrenalin.

In a lengthy decision that followed a bench trial, U.S. District Judge Joseph Bataillon in Wilmington, Delaware, said Pfizer’s proposed generic version of Adrenalin infringed two Endo patents.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below